Published on 09/07/2021
12-15 November, 2021 Hybrid edition
Âé¶¹ÆÆ½â°æ will attend the 2021 edition of AASLD / The Liver meeting.
Âé¶¹ÆÆ½â°æ announces completion and topline data from Phase 2 ALPESTRIA-1 clinical study in Alport syndrome demonstrating Vonafexor reverses kidney function decline and has sustai...